Teladoc Health Reports Third Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Teladoc (TDOC) Tops Q3 EPS by 12c, Revenues Beat; Updates FY19 EPS/Revenue Guidance Above Consensus, Affirms Q4 EPS/Revenue Views
October 30, 2019 5:07 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $138 million versus the consensus estimate of $136.47 million.
Year-over-year Q3 revenue grows 24% to $138.0 million and total visits increase 45% to 928,000Year-over-year nine months revenue grows 34% to $396.8 million and total visits increase 63% to 2,899,000Issues 2019 fourth-quarter guidance and updates full-year expectationsThe third quarter marked a continuation of Teladoc Healths very strong momentum from the first half of the year, as we... More
